Overview of HIV associated (Mutation)

ID Literature Title Group
1 17194486 Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan
Mutation
2 18052601 N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance
Mutation
3 28099515 Polymorphisms and Mutational Covariation Associated with Death in a Prospective Cohort of HIV/AIDS Patients Receiving Long-Term ART in China
Mutation
4 29698467 HIV-1 genetic transmission networks among men who have sex with men in Kunming, China
Mutation
5 30061964 Antiretroviral resistance among HIV-1 patients on first-line therapy attending a comprehensive care clinic in Kenyatta National Hospital, Kenya: a retrospective analysis
Mutation
6 30442114 Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China
Mutation
7 31190911 Antiretroviral drug resistance mutations among patients failing first-line treatment in Hanoi, Vietnam
Mutation
8 31574109 Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in Sao Paulo State, Brazil
Mutation
9 31767136 Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities
Mutation
10 31920003 Highly drug-resistant HIV-1 protease reveals decreased intra-subunit interactions due to clusters of mutations
Mutation
11 32218587 Characterization of HIV-1 genetic diversity and antiretroviral resistance in the state of Maranhao, Northeast Brazil
Mutation
12 32280691 HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016
Mutation
13 32295123 Molecular Epidemiology of the HIV-1 Subtype B Sub-Epidemic in Bulgaria
Mutation
14 32368103 HIV-1 Drug Resistance in ART-Naive Individuals in Myanmar
Mutation
15 32381145 The characteristics of pretreatment HIV-1 drug resistance in western Yunnan, China
Mutation
16 32994325 CPSF6-Dependent Targeting of Speckle-Associated Domains Distinguishes Primate from Nonprimate Lentiviral Integration
Mutation
17 33143751 Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria
Mutation
18 33692637 First-Line Antiretroviral Regimen Failure and Determinants in an Urban HIV Clinic at Phramongkutklao Hospital, Bangkok, Thailand: 20 Years Experience
Mutation
19 40106654 Mutations associated with viral resistance to integrase in individuals initiating dolutegravir-containing antiretroviral therapy: retrospective cohort, Brazil 2017-2019
Mutation
20 40146807 Cabotegravir/rilpivirine resistance in a patient living with HIV despite on-time administration: A case report
Mutation
21 16207371 HIV-1 reverse transcriptase mutations that confer decreased in vitro susceptibility to anti-RT DNA aptamer RT1t49 confer cross resistance to other anti-RT aptamers but not to standard RT inhibitors
Mutation
22 17352531 A look inside HIV resistance through retroviral protease interaction maps
Mutation
23 17442099 Immunization with HIV protease peptides linked to syngeneic erythrocytes
Mutation
24 17644816 Active site binding and sequence requirements for inhibition of HIV-1 reverse transcriptase by the RT1 family of single-stranded DNA aptamers
Mutation
25 17910056 Biophysical characterization of Vpu from HIV-1 suggests a channel-pore dualism
Mutation
26 18597780 Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir
Mutation
27 18702518 Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants
Mutation
28 18808097 Solution kinetics measurements suggest HIV-1 protease has two binding sites for darunavir and amprenavir
Mutation
29 22643973 Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling
Mutation
30 24211331 Molecular mechanism of HIV-1 resistance to 3'-azido-2',3'-dideoxyguanosine
Mutation
31 24796579 In silico prediction of mutant HIV-1 proteases cleaving a target sequence
Mutation
32 25362963 Revealing origin of decrease in potency of darunavir and amprenavir against HIV-2 relative to HIV-1 protease by molecular dynamics simulations
Mutation
33 25394027 The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound
Mutation
34 26012849 Effects of drug-resistant mutations on the dynamic properties of HIV-1 protease and inhibition by Amprenavir and Darunavir
Mutation
35 27240358 Computational Studies of a Mechanism for Binding and Drug Resistance in the Wild Type and Four Mutations of HIV-1 Protease with a GRL-0519 Inhibitor
Mutation
36 27992544 Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics
Mutation
37 28155724 Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistance
Mutation
38 30302011 Structural Rearrangements Maintain the Glycan Shield of an HIV-1 Envelope Trimer After the Loss of a Glycan
Mutation
39 30560871 Characterizing early drug resistance-related events using geometric ensembles from HIV protease dynamics
Mutation
40 30788976 Synthesis and anti-human immunodeficiency virus activity of substituted ( o,o-difluorophenyl)-linked-pyrimidines as potent non-nucleoside reverse transcriptase inhibitors
Mutation
41 30918485 The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis
Mutation
42 33314454 A synergy of activity, stability, and inhibitor-interaction of HIV-1 protease mutants evolved under drug-pressure
Mutation
43 33466381 Does Antibody Stabilize the Ligand Binding in GP120 of HIV-1 Envelope Protein? Evidence from MD Simulation
Mutation
Contents
Description
Disease Group Note
  • The label in Group indicates that the disease is mentioned in mutation or integration research. Click the eye label to view the corresponding module information.